|
ZNF148 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.789400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.003600E-01 |
| Normal-vs-Stage2 |
6.673200E-01 |
| Normal-vs-Stage3 |
3.867200E-01 |
| Normal-vs-Stage4 |
5.621200E-03 |
| Stage1-vs-Stage2 |
9.093400E-01 |
| Stage1-vs-Stage3 |
7.845600E-01 |
| Stage1-vs-Stage4 |
4.961800E-02 |
| Stage2-vs-Stage3 |
7.362800E-01 |
| Stage2-vs-Stage4 |
1.130760E-01 |
| Stage3-vs-Stage4 |
2.343400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.927400E-01 |
| Normal-vs-AfricanAmerican |
2.226200E-01 |
| Normal-vs-Asian |
2.018300E-02 |
| Caucasian-vs-AfricanAmerican |
3.920600E-01 |
| Caucasian-vs-Asian |
3.733200E-01 |
| AfricanAmerican-vs-Asian |
3.420600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.942500E-02 |
| Normal-vs-Female |
1.131000E-01 |
| Male-vs-Female |
9.323800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.218200E-01 |
| Normal-vs-Extreme_Weight |
2.584200E-01 |
| Normal-vs-Obese |
7.812800E-01 |
| Normal-vs-Extreme_Obese |
3.777800E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.309000E-01 |
| Normal_Weight-vs-Obese |
3.620600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.652800E-01 |
| Extreme_Weight-vs-Obese |
4.186600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.066800E-01 |
| Obese-vs-Extreme_Obese |
5.358000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.831200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.961800E-01 |
| Normal-vs-Age(61-80Yrs) |
5.529600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.286150E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.758590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.917000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.919800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.200200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.675500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.683200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.659200E-01 |
| Normal-VS-Type2 PRCC |
9.019400E-03 |
| Normal-VS-KIRP CIMP |
4.258300E-02 |
| Normal-VS-Unclassified PRCC |
7.945200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.395000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.367800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.961800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.495000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.954200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.447560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.958700E-03 |
| Normal-vs-N1 |
9.480000E-01 |
| Normal-vs-N2 |
4.601100E-03 |
| N0-vs-N1 |
1.094610E-01 |
| N0-vs-N2 |
3.719400E-01 |
| N1-vs-N2 |
2.097000E-01 |
|
|
